ArticleConservation biology : the journal of the Society for Conservation Biology2025
A roadmap to sustainable management of commercial medicinal and aromatic plants, fungi, and lichens in Nepal.
Article in Conservation biology : the journal of the Society for Conservation Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Divergent Effects of Climate Change on the Potential Habitats of Two Medicinally ImportantEcology and evolution · 2026Article
- A roadmap to sustainable management of commercial medicinal and aromatic plants, fungi, and lichens in Nepal.Conservation biology : the journal of the Society for Conservation Biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Thousands of plants, fungi, and lichen species are traded every year. Although sustainable use is critical for livelihoods and biodiversity conservation, insufficient data prevent detailed sustainability assessments for most species. How can the sustainability of trade in such data-deficient species be enhanced? We considered a country-level example of 300 medicinal and aromatic plant, fungus, and lichen species traded in tens of thousands of tons worth tens of millions of US dollars in and from Nepal annually. Past interventions have not ensured sustainable trade, leaving species vulnerable to commercial harvesting and threatening rural household incomes, the processing industry, and government revenues. Building on documented evidence and stakeholder involvement, we used a theory of change approach to develop a sustainable management approach. We produced a draft plan (roadmap) by combining interventions proposed at annual key stakeholder dialogue meetings with recommendations extracted from a literature review on the trade and conservation of commercial medicinal and aromatic plants, fungi, and lichens in Nepal. The draft roadmap was discussed at a national workshop with sector-wide stakeholder representation to derive the final roadmap. The literature review showed the 41 causal assumptions and theoretical explanations for actions and outcomes. Feedback mechanisms included 6 bundles of mutually reinforcing actions, such as the relationship between increased cultivation and decreased wild harvesting. The roadmap has 5 pathways: increase cultivation, strengthen local management, support domestic businesses, improve sector governance, and increase international collaboration. Each pathway is associated with 2-5 actions (e.g., hand over high-elevation areas to local communities) that lead to outputs (2-5) (e.g., an increased area under local management) and outcomes (2-6) (e.g., less overharvesting). Accordingly, the roadmap offers stakeholders a structured approach to implement future activities and investments to enhance sustainable trade. The approach can be replicated for other countries and products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.